These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 13573122)

  • 21. Treatment of urinary schistosomiasis with nilodin.
    MESSENT JJ
    Trans R Soc Trop Med Hyg; 1951 Aug; 45(1):127-9. PubMed ID: 14876772
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of Schistosoma infections in man].
    MOHR W
    Z Tropenmed Parasitol; 1957 Mar; 8(1-2):185-92. PubMed ID: 13443426
    [No Abstract]   [Full Text] [Related]  

  • 23. [Curative value of thioxanthone derivatives (miracil D and nilodin) in cases of intense parasitism by Schistosoma mansoni].
    FAIN A; LAGRANGE E
    Ann Soc Belg Med Trop (1920); 1952 Jun; 32(3):221-7. PubMed ID: 12976893
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of urinary bilharziasis with reduced dose of miracil D.
    EL-AZZAWI JA; KLIMT CR
    Bull Endem Dis (Baghdad); 1960 Jul; 3():19-23. PubMed ID: 13726289
    [No Abstract]   [Full Text] [Related]  

  • 25. Miracil D, a new chemotherapeutic agent for bilharziasis.
    HALAWANI A; WATSON JM
    J Egypt Med Assoc; 1948 Mar; 31(3):272-84. PubMed ID: 18866170
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical pathological findings in early bilharziasis.
    LURIE HI
    S Afr Med J; 1953 Nov; 27(45):1011-3. PubMed ID: 13122221
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of bladder bilharziasis in West African school children with miracil D].
    KOLLERT WF
    Z Tropenmed Parasitol; 1956 Jun; 7(2):153-62. PubMed ID: 13353430
    [No Abstract]   [Full Text] [Related]  

  • 28. Miracil D; effect on B. mansoni in vitro and in the treatment of urinary bilharziasis.
    HALAWANI A; HAFEZ A
    J Egypt Med Assoc; 1949 Jan; 32(1):29-51. PubMed ID: 18128628
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical trial of Bayer 2249 in urinary bilharziasis.
    ROSS WF
    Cent Afr J Med; 1960 Mar; 6():95-6. PubMed ID: 14439188
    [No Abstract]   [Full Text] [Related]  

  • 30. Miracil D, its toxicology, absorption, and excretion in animals and human volunteers.
    HAWKING F; ROSS WF
    Br J Pharmacol Chemother; 1948 Jun; 3(2):167-73. PubMed ID: 18866998
    [No Abstract]   [Full Text] [Related]  

  • 31. [Functional hypertrophy and hyperplasia; investigations on the intrahepatic biliary tract of the white mouse in experimental bilharziasis].
    ALTMANN HW; GONNERT R
    Beitr Pathol Anat; 1952; 112(1):8-35. PubMed ID: 14895491
    [No Abstract]   [Full Text] [Related]  

  • 32. Non-intensive chemotherapy in bilharziasis with lucanthone hydrochloride (preliminary report).
    McMahon JE
    Trans R Soc Trop Med Hyg; 1970; 64(3):433-8. PubMed ID: 5453503
    [No Abstract]   [Full Text] [Related]  

  • 33. [Miracil D treatment of schistosomiasis mansoni].
    DA SILVA JR
    Rev Bras Med; 1953 Aug; 9(8):577-81. PubMed ID: 13074715
    [No Abstract]   [Full Text] [Related]  

  • 34. Preparation 17581 (hydrochloride of I-B-diethylamino-ethlamino-4,6,8 trimethyl-azathioxanthone); clinical trials on patients infected with Schistosoma haematobium: a preliminary report.
    SHAFEI AZ
    J Egypt Med Assoc; 1958; 41(1):6-10. PubMed ID: 13575619
    [No Abstract]   [Full Text] [Related]  

  • 35. [Schistosomiasis of the urinary tract and therapeutic results with Miracil-D].
    GREMLIZA L
    Z Tropenmed Parasitol; 1953 Jun; 4(3):394-410. PubMed ID: 13103584
    [No Abstract]   [Full Text] [Related]  

  • 36. Observations on the pharmacology of miracil, a new chemotherapeutic agent for schistosomiasis.
    WOOD DR
    Q J Pharm Pharmacol; 1947; 20(1):31-7. PubMed ID: 20252809
    [No Abstract]   [Full Text] [Related]  

  • 37. Lucanthone resinates in schistosomiasis.
    DAVIS A
    Lancet; 1961 Jan; 1(7170):201-2. PubMed ID: 13720136
    [No Abstract]   [Full Text] [Related]  

  • 38. [Considerations on a new anti-schistosoma agent derived from thioxanthone: 1-(2-diethylaminoethylamino)-4,6,8-trimethyl-5-aza-9-xanthenethione hydrochloride].
    SANKALE M; RIVOALEN A; MILHADE J; LE VIGUELLOUX J
    Bull Soc Pathol Exot Filiales; 1957; 50(6):917-23. PubMed ID: 13536758
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of miracil D on human schistosomiasis.
    BLAIR DM; HAWKING F; ROSS WF
    Lancet; 1947 Dec; 2(6486):911. PubMed ID: 18896093
    [No Abstract]   [Full Text] [Related]  

  • 40. Urinary schistosomiasis treated with miracil D.
    BLAIR DM; LOVERIDGE FG
    Lancet; 1949 Feb; 1(6548):344-6. PubMed ID: 18124286
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.